USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
BIOMEDOMICS, INC.
Address:
6 DAVIS DRIVE
RESEARCH TRIANGLE PARK, NC 27709
Phone:
(919) 883-5542
URL:
N/A
EIN:
205795824
DUNS:
788103971
Number of Employees:
6
Woman-Owned?:
No
Minority-Owned?:
Yes
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $469,552.00 4
SBIR Phase II $745,047.00 1

Award List:

Highly Sensitive Hand-Held Device for Quantitative Multiplex Protein Analysis Using Time-Resolved Assay

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$69,996.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Frank Wang, Director
Abstract:
The point of care (POC) testing device is a very important tool for the Army in many different applications such as assessing the extent and effects of toxic and hazardous chemical exposure during deployments. Currently, a major challenge for POC testing technology is related to achieving multiplex… More

Not Available

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$199,635.00
Agency:
HHS
Principal Investigator:
Frank Wang – (919) 883-5542
Abstract:
The contractor (BioMedomics, Inc.) proposes to develop a nanosensing platform which is a label-free, real-time multiplexed detection of cancer biomarkers with high selectivity and sensitivity using antibody-functionalized, carbon-nanotube field-effect transistor (FFT) sensor and lateral flow… More

MULTIPLEXED SENSITIVE TESTING FOR DRUGS OF ABUSE

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$99,989.00
Agency:
HHS
Principal Investigator:
Frank Wang
Abstract:
Most drugs of abuse (DOA) testing is performed in a central lab that requires the shipping of specimens, expensive equipment (GC/MS/LS), long turnaround times, and uses valuable staff resources with current testing. Current DOA point of care (POC) assays used as pre-screening assays are generally… More

Not Available

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$99,932.00
Agency:
HHS
Principal Investigator:
Phil Nyborg
Abstract:
Not Available

TAS::75 0893::TAS MULTIPLEXED SENSITIVE TESTING FOR DRUGS OF ABUSE

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$745,047.00
Agency:
HHS
Principal Investigator:
Frank Wang – 919-883-5542
Abstract:
The overall objective of this proposal is to develop a novel, simple, low-cost, on-site DOA test device and kit for measuring drugs of abuse for multiplex analysis capabilities based on the Contractor's patented ultra-sensitive Time-Resolved Luminescent Lateral Flow Assay Technology with… More